Dai-shi A. Tian
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders.
Journal: The New England journal of medicine
Published: September 02, 2026
Erk5-mediated microglial ferroptosis drives ischemic white matter damage via the Nfatc4-Clptm1l axis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 09, 2026
Ectopic B lymphocyte follicles exacerbate ischemic brain damage via MIF-CD74/CXCR4 and interferon signaling.
Journal: The Journal of clinical investigation
Published: June 17, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathy.
Journal: Med (New York, N.Y.)
Published: February 26, 2025
Diet and the Risk of Multiple Sclerosis: Evidence With UK Biobank Nested Case-Control Study and Mendelian Randomization Analysis.
Journal: Molecular nutrition & food research
Published: January 30, 2025
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis.
Journal: Cell
Published: January 29, 2025
Gut Microbiota and White Matter Integrity: A Two-Sample Mendelian Randomization Analysis.
Journal: eNeuro
Published: December 23, 2024
Identification of novel therapeutic targets for cognitive performance and associations with brain health.
Journal: Translational psychiatry
Published: May 27, 2024
Last Updated: 09/26/2026